NetScientific’s subsidiary Wanda has signed a deal with a US hospital group Dignity Health to launch a digital health oncology care platform, OncoVerse.
OncoVerse is a digital healthcare platform that will enable Dignity Health’s medical professionals to make informed oncological treatment decisions.
The platform will expand the geographic reach of its clinical decision-making support system to rural and remote areas, allowing all patients to benefit from insights.
It also allows the medical professionals to highlight the cancer related cases for evidence-based peer collaboration, review, treatment recommendations and second opinions that are available 24/7 from any computer or other web-enabled device.
Wanda and Dignity Health is said to jointly market the Oncoverse platform to other oncology programmes across the US later this year.
The agreement will also facilitate a cross-marketing of existing and future Wanda products.
NetScientific CEO Francois Martelet said: "Wanda is the Group’s lead subsidiary in our digital health franchise.
"The launch of Oncoverse with Dignity Health, and its huge US network, is a significant milestone for the company and further endorses its core technology.
"This deal marks the second partnership that Wanda has secured with a leading US healthcare group since the start of 2016 as it continues to develop more platforms to better manage chronic conditions."
Last month, Wanda signed a deal with Chicago-based Health Resource Solutions (HRS), to supply its chronic condition digital management system to monitor patients, observe symptoms and control the chances of hospitalisations.
